AI Medical has revealed corporates including Japan Post, Aflac and Sumitomo Mitsui Banking Corporation among others as backers to its previously announced series B round.

Vita-Salute San Raffaele University-founded Genenta has now assembled $35.4m altogether to progress gene therapies for cancer targeting haematopoietic stem and progenitor cells.

Agilent Technologies has led a series A round for MobiLion Systems, a biopharmaceutical analysis instrument tool developer spun out of Pacific Northwest National Laboratory.

IP Group has backed MobiLion Systems, a biopharmaceutical analysis instrument tool developer founded by its former director of technology and business development Melissa Sherman.

Pfizer Ventures co-led the round for neurodegenerative disease medicine developer Arkuda Therapeutics, which aims to combat a certain form of dementia.

Alibaba's nonprofit Hong Kong Entrepreneurs Fund will move into biotech, augmenting its existing portfolio focus on AI, fintech and smart cities.

ScienceValue Heidelberg will handle tech transfer on behalf of the medicine faculty, after the contract with Heidelberg University Hospital-controlled TTH broke down.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Iqvia-backed medical marketing communications platform Naxions will pump the fresh capital into R&D, new product launches and customer relations.

Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.